In addition, kynurenine acts via AHR to degrade the adhesion molecule E-cadherin, resulting in enhanced tumor invasion, which is reduced by 1-MT, probably consistent with a role for IDO1 or IDO2. Here, IDO1 is linked to neoplasm.